Related Experiment Video

Updated: Mar 17, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

945

Insulin receptor substrate-1 deficiency drives a proinflammatory phenotype in KRAS mutant lung adenocarcinoma

Heather E Metz1, Julia Kargl2, Stephanie E Busch3

  • 1Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; Department of Pathology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109;

Proceedings of the National Academy of Sciences of the United States of America
|July 22, 2016
PubMed

Insights

Insulin receptor substrate-1 (IRS-1) deficiency surprisingly worsens lung cancer survival by promoting inflammation via JAK/STAT signaling. Inhibiting this pathway reduced tumor growth, especially in IRS-1-deficient tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Insulin receptor substrate-1 (IRS-1) is a key signaling adaptor in cancer.
  • IRS-1 is typically thought to promote tumor growth via PI3K signaling.
  • Its role in lung cancer, particularly KRAS-mutant adenocarcinoma, requires further investigation.

Purpose of the Study:

  • To investigate the role of IRS-1 in lung cancer progression and survival.
  • To elucidate the molecular mechanisms by which IRS-1 influences tumor growth.
  • To evaluate the therapeutic potential of targeting IRS-1-associated pathways.

Main Methods:

  • Analysis of human lung adenocarcinoma tissue microarrays for IRS-1 expression and survival correlation.
  • Generation and analysis of genetically engineered mouse models (Kras/Irs-1(-/-)) to study IRS-1 deficiency in vivo.
  • Investigating downstream signaling pathways, including JAK/STAT, in response to IRS-1 loss.
  • Pharmacological inhibition of JAK/STAT signaling in mouse models.

Main Results:

  • Reduced IRS-1 staining in human lung tumors correlated with decreased patient survival, particularly in KRAS-mutant cases.
  • Kras/Irs-1(-/-) mice exhibited increased tumor burden and mortality.
  • IRS-1 deficiency enhanced JAK/STAT signaling through the IL-22 receptor, promoting inflammation.
  • JAK inhibitor treatment significantly reduced tumor burden in both wild-type and IRS-1-deficient mice, with a more pronounced effect in the latter.

Conclusions:

  • Contrary to expectations, IRS-1 loss exacerbates lung cancer progression and mortality.
  • IRS-1 deficiency promotes tumor growth by activating pro-inflammatory JAK/STAT signaling.
  • Targeting the JAK/STAT pathway represents a promising therapeutic strategy for lung cancer, especially in IRS-1-deficient contexts.
Keywords:
Krasadenocarcinomainsulin receptor substrate-1lung

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.8K
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

3.6K

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K